News

GlaxoSmithKline to publish clinical trials after US lawsuit

BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7455.1513-a (Published 24 June 2004) Cite this as: BMJ 2004;328:1513

This article has a correction. Please see:

  1. Liza Gibson
  1. London

    The world's second largest pharmaceutical company, GlaxoSmithKline, is to publish summaries of the results of all its clinical trials on its website once a product has been launched.

    GlaxoSmithKline said it has been considering the move for several months now, but it follows on the heels of a US lawsuit, filed by Eliot Spitzer, New York state's attorney general, earlier this month.

    Mr Spitzer alleged the company engaged in “repeated and persistent fraud” for concealing the results of clinical studies for its antidepressant paroxetine; these suggested the drug was ineffective and unsafe in treating depression in children and adolescents (12 June, p 1395).

    Mr Spitzer also had an internal …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe